TriSalus Life Sciences (TLSIW) Current Leases (2022 - 2026)

TriSalus Life Sciences has reported Current Leases for 5 years, with the latest figure at $218000.0 in Q1 2026.

• For the quarter ending Q1 2026, Current Leases rose 84.75% year-over-year to $218000.0; the trailing twelve-month figure through Mar 2026 stood at $218000.0 (up 84.75% YoY), and the FY2025 full-year result was $167000.0, down 22.69% from the prior year.
• Current Leases for Q1 2026 stood at $218000.0, up from $167000.0 in the prior quarter.
• The five-year high for Current Leases was $379000.0 in Q3 2023, with the low at $118000.0 in Q1 2025.
• Historically, Current Leases has averaged $251916.7 across 5 years, with a median of $242000.0 in 2024.
• Annual changes were most pronounced in 2025 — Current Leases sank 67.49% — and 2026, when it soared 84.75%.
• TriSalus Life Sciences' Current Leases stood at $370000.0 in 2022, then slipped by 5.14% to $351000.0 in 2023, then slumped by 38.46% to $216000.0 in 2024, then decreased by 22.69% to $167000.0 in 2025, then surged by 30.54% to $218000.0 in 2026.
• The last three Current Leases figures came in at $218000.0 (Q1 2026), $167000.0 (Q4 2025), and $129000.0 (Q3 2025), per Business Quant data.